Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Health Law and Policy (2)
- Insurance Law (2)
- Antitrust (1)
- Biomedical innovations (1)
- Civil Rights (1)
-
- Conflict of Laws (1)
- Constitutional Law (1)
- Dispute Resolution (1)
- Domestic Relations (1)
- Economics (1)
- Employment Practice (1)
- Family Law, Contract Law, Modern Contract Law, Surrogacy Contract/Agreement, Change of Heart, Unequal Power of the Contracting Parties, Changed Circumstances, Renegotiation, Unconscionability, Surrogate Mother, Motherhood, Parent-Child, Surrogacy, Intended Parent, Intentional Parenthood. (1)
- Food and Drug Law (1)
- Health (1)
- Health Insurance (1)
- Health Law (1)
- Healthcare Drug Spend (1)
- Human Rights Law (1)
- Insurance Policies (1)
- Intellectual Property Law (1)
- Law and Economics (1)
- Law and Society (1)
- Law and Technology (1)
- Legislation (1)
- Medical Jurisprudence (1)
- Most Favored Customer (1)
- Most Favored Nation (1)
- Politics (1)
- Science and Technology (1)
- Publication
- Publication Type
- File Type
Articles 1 - 3 of 3
Full-Text Articles in Contracts
Waging War On Specialty Pharmaceutical Tiering In Pharmacy Benefit Design, Chad I. Brooker
Waging War On Specialty Pharmaceutical Tiering In Pharmacy Benefit Design, Chad I. Brooker
Chad I Brooker
Specialty drugs represent a growing concern for both health insurance issuers and beneficiaries given their exceedingly high (and growing) costs—representing almost half of all drug spend by 2017. Payers have sought to reduce their specialty drug spend by sharing more of the cost of these drugs with the beneficiaries who depend on them through the creation of specialty drug tiers. This has forced some patients to choose between forgoing other needs to pay for their medications or not take them at all. While several states have sought to outlaw the use of specialty drug tiers or limit pharmaceutical OOP cost-sharing, …
The New Frontier Of Advanced Reproductive Technology: Reevaluating Modern Legal Parenthood, Yehezkel H. Margalit Dr., John D. Loike Dr., Orrie Levy Adv.
The New Frontier Of Advanced Reproductive Technology: Reevaluating Modern Legal Parenthood, Yehezkel H. Margalit Dr., John D. Loike Dr., Orrie Levy Adv.
Hezi Margalit
Assisted reproductive technologies (ARTs) have challenged our deepest conceptions of what it means to be a parent by fragmenting traditional aspects of parenthood. The law has been slow to respond to this challenge, and numerous academic articles have proposed models for adapting parentage laws to ARTs. In the coming years, however, scientific advancements in reproductive technologies, such as somatic cell nuclear transfer and stem cell technologies, will challenge both parentage laws and proposed legal models for traditional ARTs in new and fascinating ways. For instance, these advanced technologies could allow two women to create a child without any male genetic …
The Competitive Consequences Of Most-Favored-Nation Provisions, Jonathan Baker, Judith A. Chevalier
The Competitive Consequences Of Most-Favored-Nation Provisions, Jonathan Baker, Judith A. Chevalier
Articles in Law Reviews & Other Academic Journals
"Most Favored Nation" contractual provisions have come under scrutiny in recent years by antitrust authorities in both the US and EU. MFNs are a type of vertical agreement between suppliers and buyers. The literature has recognized that there may be efficiency rationales for these arrangements but the literature has also recognized that these arrangements have anticompetitive potential. In this paper, we distill the economics literature on MFNs to explore both possibilities.